Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized double-blind multicenter trial of Zhibitai capsules for primary hyperlipidemia
CTR20250051Phase 2Completed
- Sponsor
- Chengdu Diao Jiuhong Pharmaceutical
- Start
- Mar 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of zhibitai in familial hyperlipidemia, sponsored by Chengdu Diao Jiuhong Pharmaceutical. Started Mar 2025; status: completed.
02
Drugs
zhibitai
03
Conditions
familial hyperlipidemia
Beyond the preview
Go deeper on CTR20250051.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20250051.